EMTT Therapy in Brooklyn, NY

Extracorporeal Magnetotransduction Therapy is a non-invasive regenerative treatment that uses high-energy electromagnetic pulses to stimulate biological healing processes in musculoskeletal tissue. It is commonly used for chronic tendon injuries, joint pain, overuse conditions, and sports-related injuries.

No. While both therapies use electromagnetic energy, Extracorporeal Magnetotransduction Therapy delivers significantly higher-energy pulses and is designed to stimulate deeper biological responses in injured tissue. PEMF devices typically operate at lower energy levels and are often used for general wellness or home therapy. EMTT is commonly integrated into structured rehabilitation programs.

Patients often ask whether Extracorporeal Magnetotransduction Therapy is similar to pulsed electromagnetic field therapy. You can read a detailed comparison in Dr. Patane’s blog post on PEMF vs Extracorporeal Magnetotransduction Therapy.

Treatment frequency depends on the condition being addressed, how long symptoms have been present, tissue tolerance, and overall rehabilitation strategy.

Within multimodal regenerative care plans, patients often undergo a series of approximately six structured treatment visits that may combine shockwave therapy (radial EPAT or focused ESWT) with Extracorporeal Magnetotransduction Therapy. Depending on clinical response, an additional standalone Extracorporeal Magnetotransduction Therapy session may also be incorporated during this period.

When used independently, Extracorporeal Magnetotransduction Therapy is commonly delivered around two times per week for several weeks to support tissue healing and functional improvement. Treatment plans are individualized and may be modified based on progress and activity goals.

Extracorporeal Magnetotransduction Therapy is non-invasive and usually requires little to no downtime. Most patients can return to normal daily activity the same day unless specific activity modifications are recommended.

The electromagnetic portion of treatment is typically brief. Total appointment time may vary depending on whether Extracorporeal Magnetotransduction Therapy is combined with other therapies such as shockwave treatment, rehabilitation exercises, or movement assessment.

Most patients tolerate Extracorporeal Magnetotransduction Therapy very well. Sensations during treatment can vary depending on the area being treated and individual tissue sensitivity.

Most patients describe the sensation as unusual rather than painful.

Certain regions of the body — such as the shoulder, sacroiliac (SI) joint, or Achilles tendon — are often more sensitive and patients may feel a noticeable pulsing or deep stimulation during treatment. In other areas, or in individuals with lower sensitivity, the therapy may be only mildly perceptible or not strongly felt at all.

Extracorporeal Magnetotransduction Therapy is non-invasive and does not involve injections or surgical procedures. Treatment intensity can be adjusted to maintain comfort while still supporting therapeutic goals.

Yes. In most cases, Extracorporeal Magnetotransduction Therapy is combined with shockwave therapy — including radial shockwave therapy (EPAT) or focused shockwave therapy (ESWT) — particularly during the initial phase of a multimodal regenerative treatment approach.

These therapies influence tissue healing through different physiological mechanisms and may be used together to provide a more comprehensive stimulus for recovery in chronic or complex musculoskeletal conditions.

Treatment recommendations depend on the specific injury, tissue response, activity goals, and overall rehabilitation strategy. In some situations, Extracorporeal Magnetotransduction Therapy may also be used as a standalone treatment when clinically appropriate.

Treatment cost depends on the condition being treated, the number of areas involved, and whether Extracorporeal Magnetotransduction Therapy is used as a standalone treatment or combined with other regenerative therapies and rehabilitation.

In general, standalone Extracorporeal Magnetotransduction Therapy sessions are typically around $100 per visit. In many cases, treatment is provided as part of a structured regenerative care program that may include radial shockwave therapy (EPAT), focused shockwave therapy (ESWT), and progressive rehabilitation. When included within a comprehensive treatment package, the cost of individual Extracorporeal Magnetotransduction Therapy sessions may be incorporated into the overall program.

Structured regenerative treatment plans are designed to address both pain and underlying tissue dysfunction in order to support longer-term recovery and reduce recurrence risk.

A clinical evaluation helps determine the most appropriate treatment approach and overall program structure based on your condition and recovery goals.

Patients experiencing chronic pain, tendon injuries, sports injuries, overuse conditions, or slow-healing musculoskeletal tissue may benefit from this treatment. A clinical evaluation is recommended to determine whether Extracorporeal Magnetotransduction Therapy is appropriate.

Return-to-activity recommendations depend on the condition being treated, symptom severity, and the overall rehabilitation plan.

Many patients are able to continue modified training while undergoing Extracorporeal Magnetotransduction Therapy. Running or exercise is often permitted as long as the activity is not significantly increasing pain, worsening symptoms, or delaying tissue healing. Training volume, intensity, or frequency may be temporarily adjusted to support recovery.

In some cases, a structured running analysis or movement assessment may be recommended to help identify loading patterns or biomechanical factors that contributed to the injury. Addressing these factors can support a safer and more confident return to running.

Progression back to full activity is guided by symptom response, tissue tolerance, and functional improvement.

The goal is usually to keep you moving while allowing the injured tissue to recover.